Status:
WITHDRAWN
Hartmann's Solution and Normal Saline in Type II Diabetes Patients
Lead Sponsor:
Yeungnam University College of Medicine
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether perioperative use of Hartmann's solution in type II diabetes patients increases blood glucose level after surgery. The investigators expect the result...
Detailed Description
Hyperglycemia is an independent risk factor for poor outcomes in diabetic patients experiencing sudden cardiac death, myocardial infarction, cerebrovascular accident. During surgery, activation of the...
Eligibility Criteria
Inclusion
- Type II diabetes patients who are included in American Society of Anesthesiologists Physical Status Classification I-III.
Exclusion
- emergency surgery, acute or chronic kidney disease, electrolyte imbalance such as hypernatremia, hyponatremia, hyperkalemia or hypokalemia, liver dysfunction, unexpected hemodynamic instability due to excess bleeding, postoperative ventilatory care and trauma patients.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02305199
Start Date
January 1 2015
End Date
April 1 2017
Last Update
April 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yeungnam University Hospital
Daegu, South Korea, 705-717